Table 3. The improvement of immunoscore-based prognostic nomogram in predicting OS according to NRI and IDI.
| OS | Immunoscore-based prognostic nomogram vs. MI |
Immunoscore-based prognostic nomogram vs. TNM stage |
Immunoscore-based prognostic nomogram vs. LMR |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NRI (95%CI) | P | IDI (95%CI) | P | NRI (95%CI) | P | IDI (95%CI) | P | NRI (95%CI) | P | IDI (95%CI) | P | |||
| 1-year | 0.500 (0.187–0.761) |
<0.001 | 0.021 (0.005–0.052) |
<0.001 | 0.370 (0.057–0.643) |
0.02 | 0.055 (0.018–0.121) |
<0.001 | 0.399 (0.089–0.676) |
<0.001 | 0.054 (0.022–0.115) |
<0.001 | ||
| 3-year | 0.597 (0.417–0.740) |
<0.001 | 0.077 (0.037–0.136) |
<0.001 | 0.531 (0.384–0.666) |
<0.001 | 0.173 (0.098–0.260) |
<0.001 | 0.366 (0.199–0.634) |
<0.001 | 0.164 (0.099–0.259) |
<0.001 | ||
| 5-year | 0.493 (0.389–0.616) |
<0.001 | 0.106 (0.057–0.169) |
<0.001 | 0.404 (0.274–0.535) |
<0.001 | 0.249 (0.145–0.363) |
<0.001 | 0.255 (0.122–0.515) |
<0.001 | 0.226 (0.131–0.335) |
<0.001 | ||
LMR, lymphocyte-to-monocyte ratio; NRI, net reclassification improvement; IDI, integrated discrimination improvement.